ICON Central Laboratories ‘Stands out as Service Provider that is more often than not Exceeding Sponsors’ Expectations’
18 Novembre 2010 - 1:54PM
Business Wire
ICON Central Laboratories - a division of ICON plc,
(NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced
development services to the pharmaceutical, biotechnology and
medical device industries - today announced results from a recent
global industry research report indicating that it ‘stands out as
the service provider that is more often than not exceeding
sponsors’ expectations’.
‘The State of the Central Labs Market’ report, published by
Industry Standard Reports (ISR), examines the underlying dynamics
of the central laboratory services market and provides an analysis
of the key factors influencing satisfaction in central laboratories
relationships by comparing the strengths and weaknesses of the top
seven global central laboratories by market share. Its findings are
based on data generated from 105 survey respondents from 75 unique
sponsor companies, all with decision-making authority for central
laboratories services.
The report found that ICON Central Laboratories currently
exceeds all competitors in three key areas: sample turnaround
times, geographic coverage and high value at low cost. According to
the report, ICON Central Laboratories ‘have focused their delivery
on a core set of tests and are providing them with a high degree of
quality coupled with excellent project management capabilities.’
The report goes on to say, ‘ICON is separating itself from its
peers in terms of the traditional cost/ value matrix, [by]… meeting
expectations for low cost while performing very well and delivering
high value.’
Commenting on the report, Tom O’Leary, President, ICON Central
Laboratories, said, “We’re delighted with the findings of Industry
Standard Research’s latest report which demonstrates that here at
ICON Central Laboratories, we continue to outperform our
competitors in key areas such as sample turnaround times,
geographic coverage and high value at low cost. We’re particularly
pleased with the finding that we’re the top rated central
laboratory services provider for meeting customers’ quality and
project management expectations. This finding reflects quality
improvement initiatives we have put in place for our customers such
as Six Sigma methodologies and MCC metrics for quality and
timeliness.”
Notes to Editors:
About ICON plc:
ICON plc is a global provider of outsourced development services
to the pharmaceutical, biotechnology and medical device industries.
The Company specialises in the strategic development, management
and analysis of programs that support clinical development - from
compound selection to Phase I-IV clinical studies. ICON currently
employs almost 7,800 employees, operating from 71 locations in 39
countries.
For further information, please visit www.iconplc.com
About ICON Central Laboratories
ICON Central Laboratories, a division of ICON plc, provides full
service, global central laboratory services from core facilities in
the U.S., Ireland, Singapore, India and China. An extensive test
menu of safety, esoteric and custom-developed assays, including
global flow cytometry, is complemented by dedicated,
sponsor-specific project teams and a single, comprehensive database
for each study as well as a user-friendly, web-based, secure remote
data access system. ICON Central Laboratories also offers a unique
service to manage and compile laboratory data when a client’s study
requires the use of local laboratories.
For further information, please visit
http://www.iconplc.com/company/service-divisions/icon-central-laboratories/
ICON/ICLR-G
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024